Lopital is one of the market leaders in the Netherlands in the field of innovative hygiene and transfer aids to prevent physical overload and reduce work pressure within healthcare organizations.
In portfolio since August 2023
Growth & Buy-out
- Praktische GGZ
- ad Astra
Founded in 1977, Lopital operates in more than 25 countries with a team of 47 employees. Lopital develops, assembles and implements a wide range of durable, (MDR) certified and high quality devices to prevent physical overload and reduce work pressure within healthcare facilities, hospitals and home care. Lopital products have a major impact on the well-being and health of clients and healthcare workers.
Why are we investing in Lopital?
There stands a powerful company with an excellent foundation from which we will realize our growth ambitions. Holland Capital supports the organization in its growth plans by focusing on both organic growth (portfolio development), the development of new business models and value propositions, and buy-and-build opportunities, and that nationally and internationally.
“After 39 years, it was time to hand over the baton and we have been able to ensure that the future of Lopital and its employees is assured with the bringing in of new CEO Jan van Megen and with Holland Capital as an experienced investor. It has been an unforgettable journey for us, in which the healthcare landscape has changed incredibly and in which we have been able to play a beautiful role.”